High levels of miRNA-18 combined with low levels of the TGFβ metagene correlated with prolonged patient survival and thus it was postulated that low expression of miRNA-18a may significantly contribute to GBM pathogenesis [41]. The gene discussed is TGFB1; the disease is glioblastoma.